CompletedNCT05660070
This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
CompletedNCT06225115
This study exists to compare options and see whether the medication KYN-5356 offers something meaningfully different. Researchers are trying to understand how people respond to the medication KYN-5356 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Kynexis B.V.
- Condition
- Schizophrenia
CompletedNCT05136690
This study exists to compare options and see whether the medication MK-4334 offers something meaningfully different. Researchers are trying to understand what the medication MK-4334 could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Merck Sharp & Dohme LLC
- Condition
- Schizophrenia
CompletedNCT03583073
This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 12 Years to 17 Years
- Countries
- United States
- Sponsor
- Brown University
- Condition
- Schizophrenia
RecruitingNCT05457140
This study exists to see whether this type of care can make care clearer and more responsive. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 7 Years to 17 Years
- Countries
- United States
- Sponsor
- Rady Pediatric Genomics & Systems Medicine Institute
- Condition
- Schizophrenia
CompletedNCT03557931
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Astellas Pharma Global Development, Inc.
- Condition
- Schizophrenia
TerminatedNCT05654870
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
SchizophreniaOtherOver 13 Years
- Countries
- United States
- Sponsor
- Neurocrine Biosciences
- Condition
- Schizophrenia
CompletedNCT05105542
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT03621774
This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
CompletedNCT04959032
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- Bulgaria, Poland, Serbia, United States
- Sponsor
- Intra-Cellular Therapies, Inc.
- Condition
- Schizophrenia
CompletedNCT02720263
This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Astellas Pharma Global Development, Inc.
- Condition
- Schizophrenia
CompletedNCT03356639
This study exists to better understand the safety of blood tests and biological markers and how manageable it feels in practice. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Astellas Pharma Global Development, Inc.
- Condition
- Schizophrenia
CompletedNCT04659174
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Ukraine, United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
CompletedNCT05779241
This study exists to better understand the safety of the medication LYN-005 and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication LYN-005 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Lyndra Inc.
- Condition
- Schizophrenia
CompletedNCT06653829
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- North Shore Therapeutics, Inc.
- Condition
- Schizophrenia
TerminatedNCT03437668
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Chengappa, K.N. Roy, MD
- Condition
- Schizophrenia
CompletedNCT03669250
This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand what helps a digital app or remote support tool stay useful, realistic, and easier to follow over time.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Cerevance Alpha, Inc.
- Condition
- Schizophrenia
CompletedNCT04001114
This study exists to compare options and see whether smoking support or smoking-related treatment offers something meaningfully different. Researchers are trying to understand what smoking support or smoking-related treatment could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
RecruitingNCT04046497
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 15 Years to 40 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia
RecruitingNCT04004364
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 15 Years to 40 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia
CompletedNCT01853020
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 21 Years to 35 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT03995368
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 25 Years to 55 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Schizophrenia
CompletedNCT03896438
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- University of Minnesota
- Condition
- Schizophrenia
CompletedNCT01911676
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 21 Years to 65 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT03037983
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Schizophrenia